93 7325 (Trandolapril 1 mg)

Pill with imprint 93 7325 is Beige, Capsule-shape and has been identified as Trandolapril 1 mg. It is supplied by Teva Pharmaceuticals USA.

Trandolapril is used in the treatment of high blood pressure; diabetic kidney disease; heart attack; left ventricular dysfunction; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Trandolapril 1 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7325

Trandolapril

Imprint:

93 7325

Strength:

1 mg

Color:

Beige

Size:

8.00 mm

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Angiotensin Converting Enzyme Inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Teva Pharmaceuticals USA

Inactive Ingredients:

• ferric oxide yellow
• lactose anhydrous
• povidone k30
• corn starch
• sodium stearyl fumarate
• FD&C Blue No. 2
• indigotindisulfonate sodium
• aluminum oxide
• FD&C Red No. 40
• FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
00093-7325	Teva Pharmaceuticals USA, Inc.
42291-0837	AvKare, Inc.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer